Why Lobular Breast Cancer Can be Difficult to Detect

Translate to Spanish or other 102 languages!

Reports show that one in eight women will be diagnosed with breast cancer in their lifetime. Image for illustration purposes
- Advertisement -

CLEVELAND CLINIC – October is Breast Cancer Awareness Month.

Reports show that one in eight women will be diagnosed with breast cancer in their lifetime. 

And while it is common, there are still challenges when it comes to detecting certain types – like lobular breast cancer. 

- Advertisement -

“Lobular breast cancer is our second most common type of breast cancer, behind the most common which is ductile breast cancer. Lobular breast cancers are almost always estrogen receptor positive, or they grow in response to estrogen, and the reason that lobular cancers are different than ductile cancer cells is when you look at those cancer cells under the microscope, they grow in single file lines compared to how ductile cancers typically grow in lumps or tumors,” said Megan Kruse, MD, breast oncology specialist at Cleveland Clinic. 

Dr. Kruse said since lobular breast cancer doesn’t form a lump like other kinds of breast cancers, it can be easily overlooked, not just during self-exams, but with mammograms too. 

She explains that the cancer cells can blend in with breast tissue, making it harder to detect in the early stages. 

Symptoms can also be different. 

- Advertisement -

For example, a woman may notice skin thickening or irritation but could assume it’s due to something else. 

Dr. Kruse said as a result, women are often diagnosed at a later stage. 

“Thankfully, most of these lobular cancers are hormone-driven and we have great anti-hormone therapies, anti-estrogen therapies. And so even if these cancers are diagnosed at a later stage, maybe they’re not all stage ones, there can be stage two and stage three. Those are still very much curable breast cancers,” she said. “And it may mean that the patients have a longer treatment journey. They might have more significant surgery, they might require additional medications that a patient with stage one cancer may not have, but still the goal is ultimately cure.”

Dr. Kruse emphasizes the importance of annual mammograms and also encourages women to tell their physician about any concerns. 

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

DHR Health Transplant Institute Bringing New Era to South Texas

Something significant is happening in medicine in the Rio Grande Valley. A level of specialized care that once routinely required Valley patients to travel hundreds of miles is now being delivered close to home — and earning recognition among leading kidney transplant programs in Texas and across the nation. DHR Health Transplant Institute has reached No. 2 in Texas and No. 16 nationally, marking an important moment for advanced medicine in South Texas.

DHR Health Transplant Success Signals a New Era for Advanced Medicine in the Rio Grande Valley

The significance of DHR Health Transplant Institute’s latest recognition extends far beyond a hospital ranking. It raises a larger question for South Texas: Has the Rio Grande Valley reached the point where patients can look to the region not only for local healthcare, but for nationally competitive transplant medicine?

STHS Earns Another 5-Star Healthgrades Distinction for Hip Fracture Care

For the sixth consecutive year, STHS McAllen and STHS Edinburg have earned a Five-Star Rating for Hip Fracture Treatment from Healthgrades, one of the nation's leading resources for evaluating hospital performance.

Raising Awareness, One Step at a Time: STHS Edinburg Hosts Sept. 23 Walkathon

To raise awareness about the condition and encourage residents to take proactive steps toward better vascular health, the STHS Limb Salvage & Amputation Prevention Program will host the Step Out PAD Walkathon on Wednesday, September 23, 2026, at STHS Edinburg, from 6:30 to 7:30 p.m.
- Advertisement -